AUC |
area under the curve |
BC |
breast cancer |
CAF |
cancer-associated fibroblast |
Cancer_Malig |
cancer malignant cell |
CCI |
Cell-cell interaction |
CD4+T |
CD4+ T lymphocytes |
CD8+T |
CD8+ T lymphocytes |
cDC |
conventional DC |
CRC |
colorectal cancer |
DC |
dendritic cell |
DEGs |
differentially expressed genes |
ECM |
extracellular matrix |
EMT |
epithelial-to-mesenchymal transition |
End |
endothelial cells |
ESCA |
esophageal cancer |
GIST |
gastrointestinal stromal tumor |
KM |
Kaplan–Meier |
LC |
lung cancer |
L-R |
ligand–receptor |
Macro |
macrophage |
myCAF |
myofibroblast |
NK |
natural killer |
OV |
ovarian cancer |
PC |
principal component |
PDAC |
pancreatic ductal adenocarcinoma |
pEMT |
partial epithelial-to-mesenchymal transition |
RCC |
renal cell carcinoma |
ROC |
receiver operating characteristic |
scRNA |
single-cell RNA |
ssGSEA |
single sample gene set enrichment analysis |
ST |
spatial transcriptome |
subTME |
tumor microenvironment subtype |
subTME-ICI |
immune cell infiltration tumor microenvironment subtype |
subTME-IS |
immune-suppressive tumor microenvironment subtype |
subTME-MRM |
matrix remodeling with malignant cells tumor microenvironment subtype |
subTME-PSE |
precancerous state of epithelial cells tumor microenvironment subtype |
TAM |
tumor-associated macrophage |
Teff |
T lymphocyte effector |
Tex |
T lymphocyte exhaustion |
TME |
tumor microenvironment |
Treg |
T regulatory |